Skip to Main Content
  • Yale Nephrology - DaVita Dialysis
    100 Church Street South
    New Haven, CT 06519
  • Yale Nephrology - DaVita Dialysis
    DaVita Dialysis - Hamden
    3000 Dixwell Avenue
    Hamden, CT 06518
  • Yale Nephrology - DaVita Dialysis
    DaVita Branford Dialysis Center
    249 West Main Street
    Branford, CT 06405
  • Yale Nephrology
    Yale Physicians Building
    800 Howard Avenue, Ste 2nd Floor
    New Haven, CT 06519
  • Yale Nephrology
    Yale New Haven Hospital
    20 York Street
    New Haven, CT 06510
  • Yale Nephrology
    260 Long Ridge Road
    Stamford, CT 06902

Anushree C Shirali, MD

Nephrology, Medical Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians

Biography

Anushree Shirali, MD, is a nephrologist who specializes in Onco-nephrology, a new and growing subspecialty dedicated to the care of people who have both kidney disease and cancer. “The implication of kidney disease can be big for their cancer therapy, because we are always looking at whether it is related to their treatment,” she says.

Cancer patients sometimes worry that Dr. Shirali will tell them a lifesaving immunotherapy or chemotherapy treatment they are taking is damaging their kidneys and they can no longer use the drugs. “That’s not really the case,” she says. “Our work is usually about management. There are medications that you can use to reverse kidney damage, particularly in cases where patients are receiving immunotherapy.”

After starting her career as a general nephrologist, Dr. Shirali began working with cancer patients about a decade ago, after Smilow Cancer Hospital at Yale New Haven opened, and started the Onco-nephrology specialty clinic at Yale. “This was a relatively new area in nephrology at the time and it drew me because of the complex problems it dealt with in patients facing cancer,” she says. “For me it was a very personal thing as well. I lost my father to pancreatic cancer when I was a medical student, and my mother is a breast cancer survivor. So, I understand from that perspective what happens and how vulnerable patients feel after a cancer diagnosis.”

Dr. Shirali tells her patients that fear about cancer is partly fear of the unknown, especially when it also involves issues with compromised kidney function. “Part of my job is to make a map of what lies ahead,” she says. “It becomes a little less fearful when we talk about how we will navigate the terrain together.”

While Dr. Shirali is primarily a clinician, she has a particular research interest in identifying risk factors for acute interstitial nephritis, an important cause of kidney failure that can be induced by immunotherapy in some patients.

 

 

 

Titles

  • Associate Professor of Medicine

Education & Training

  • Fellowship
    Yale University School of Medicine (2011)
  • Residency
    Montefiore Hospital (Albert Einstein College of Medicine) (2006)
  • MD
    New York Medical College (2003)
  • BS
    University of California at Davis (1997)

Additional Information

Biography

Anushree Shirali, MD, is a nephrologist who specializes in Onco-nephrology, a new and growing subspecialty dedicated to the care of people who have both kidney disease and cancer. “The implication of kidney disease can be big for their cancer therapy, because we are always looking at whether it is related to their treatment,” she says.

Cancer patients sometimes worry that Dr. Shirali will tell them a lifesaving immunotherapy or chemotherapy treatment they are taking is damaging their kidneys and they can no longer use the drugs. “That’s not really the case,” she says. “Our work is usually about management. There are medications that you can use to reverse kidney damage, particularly in cases where patients are receiving immunotherapy.”

After starting her career as a general nephrologist, Dr. Shirali began working with cancer patients about a decade ago, after Smilow Cancer Hospital at Yale New Haven opened, and started the Onco-nephrology specialty clinic at Yale. “This was a relatively new area in nephrology at the time and it drew me because of the complex problems it dealt with in patients facing cancer,” she says. “For me it was a very personal thing as well. I lost my father to pancreatic cancer when I was a medical student, and my mother is a breast cancer survivor. So, I understand from that perspective what happens and how vulnerable patients feel after a cancer diagnosis.”

Dr. Shirali tells her patients that fear about cancer is partly fear of the unknown, especially when it also involves issues with compromised kidney function. “Part of my job is to make a map of what lies ahead,” she says. “It becomes a little less fearful when we talk about how we will navigate the terrain together.”

While Dr. Shirali is primarily a clinician, she has a particular research interest in identifying risk factors for acute interstitial nephritis, an important cause of kidney failure that can be induced by immunotherapy in some patients.

 

 

 

Titles

  • Associate Professor of Medicine

Education & Training

  • Fellowship
    Yale University School of Medicine (2011)
  • Residency
    Montefiore Hospital (Albert Einstein College of Medicine) (2006)
  • MD
    New York Medical College (2003)
  • BS
    University of California at Davis (1997)

Additional Information

  • Yale Nephrology - DaVita Dialysis
    100 Church Street South
    New Haven, CT 06519
  • Yale Nephrology - DaVita Dialysis
    DaVita Dialysis - Hamden
    3000 Dixwell Avenue
    Hamden, CT 06518
  • Yale Nephrology - DaVita Dialysis
    DaVita Branford Dialysis Center
    249 West Main Street
    Branford, CT 06405
  • Yale Nephrology
    Yale Physicians Building
    800 Howard Avenue, Ste 2nd Floor
    New Haven, CT 06519
  • Yale Nephrology
    Yale New Haven Hospital
    20 York Street
    New Haven, CT 06510
  • Yale Nephrology
    260 Long Ridge Road
    Stamford, CT 06902